Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
Alzheimer Disease l: Introduction01:29

Alzheimer Disease l: Introduction

Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Modulation of pulmonary IL-21 expression during latent TB and M. tuberculosis/SIV coinfection.

JCI insight·2026
Same author

Work challenges and cancer-related cognitive impairment: level of education accounts for unmet needs beyond cognitive impairment severity.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2026
Same author

Depression, psychological distress, and coping strategies among African migrants in Australia: a cross-sectional web-based study.

BMC psychiatry·2025
Same author

Neurodegeneration Through the Lens of Bioinformatics Approaches: Computational Mechanisms of Protein Misfolding.

International journal of molecular sciences·2025
Same author

A Systematic Review and Meta-Analysis Investigating the Efficacy of Various Psychedelic Drugs for the Treatment of Substance Use Disorder.

Healthcare (Basel, Switzerland)·2025
Same author

A primer on meta-awareness of mind wandering in schizotypy and schizophrenia.

Psychological research·2025

相关实验视频

Updated: Jun 19, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 25, 2010

功能和临床:一种可解释的深度学习模型,用于多模式阿尔茨海默氏症疾病分类.

Samuel L Warren1, Ahmed A Moustafa1,2

  • 1School of Psychology, Faculty of Society and Design, Bond University, Gold Coast, Queensland, Australia.

Brain and behavior
|January 30, 2026
PubMed
概括
此摘要是机器生成的。

将功能磁共振成像 (fMRI) 与临床数据相结合,可以通过深度学习显著改善阿尔茨海默病 (AD) 的分类. 这种多式联络方法提高了模型的准确性和可解释性,以获得更好的临床应用.

关键词:
阿尔茨海默病 (AD) 是一种疾病.临床数据 临床数据深度学习是一种深度学习.默认模式网络 (DMN) 是一个默认模式网络.可解释的人工智能 (XAI)功能性磁共振成像 (fMRI) 是一种功能性磁共振成像.

更多相关视频

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

相关实验视频

Last Updated: Jun 19, 2026

Basics of Multivariate Analysis in Neuroimaging Data
06:35

Basics of Multivariate Analysis in Neuroimaging Data

Published on: July 25, 2010

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data
09:47

DeepOmicsAE: Representing Signaling Modules in Alzheimer's Disease with Deep Learning Analysis of Proteomics, Metabolomics, and Clinical Data

Published on: December 15, 2023

科学领域:

  • 神经成像是一种神经成像.
  • 人工智能的人工智能
  • 临床诊断 临床诊断 临床诊断

背景情况:

  • 使用fMRI的深度学习模型对阿尔茨海默氏症 (AD) 分类有希望.
  • 挑战包括小型数据集,缺乏可解释性,以及数据泄露等可靠性问题,阻碍临床采用.

研究的目的:

  • 开发一个可靠和可解释的多式联网深度学习模型用于AD分类.
  • 通过整合临床数据和使用可解释AI (XAI) 来解决基于fMRI模型的局限性.

主要方法:

  • 在默认模式网络和五项临床试验的fMRI数据上训练了一个3D卷积神经网络.
  • 采用多式联运数据集成和严格的leave-one-out交叉验证来克服数据限制并防止数据泄露.
  • 扰乱排名用于特征重要性分析.

主要成果:

  • 多式模式模型从对照组分类AD的准确度达到90%,明显优于仅使用fMRI (58%准确度) 的模型.
  • 根据诊断组,特征的重要性各不相同,像MoCA这样的临床测试显示了对对照组与AD患者的差异性相关性.
  • 可解释的人工智能在临床和fMRI数据中揭示了特征重要性的独特模式.

结论:

  • 将fMRI和临床数据结合在多式联络深度学习模型中,提高了AD分类的准确性,并提供了对疾病特征的见解.
  • 开发的模型表明了改进阿尔茨海默病诊断工具的潜力.
  • 建议使用更大的样本大小进行进一步的外部验证.